Quoin Pharmaceuticals, Ltd. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Quoin Pharmaceuticals, Ltd. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Quoin Pharmaceuticals, Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $6.22M, a 41.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.22M +$1.82M +41.5% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $4.39M +$347K +8.58% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $4.05M +$2.18M +117% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $1.87M Dec 31, 2020 20-F 2022-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.